Brief: Celadon Pharmaceuticals Makes Submissions To MHRA As Part Of Its GMP Registration

Celadon Pharmaceuticals

22/12/2022 08:03

Dec 22 (Reuters) - Celadon Pharmaceuticals PLC  CEL.L :
    * CELADON PHARMA. PLC  - UPDATE ON GMP REGISTRATION BY MHRA
    * CELADON PHARMACEUTICALS PLC - CELADON HAS SUCCESSFULLY
MADE
NECESSARY SUBMISSIONS TO MHRA AS PART OF ITS GMP REGISTRATION
    * CELADON PHARMACEUTICALS PLC - CELADON CAN CONFIRM THAT NO
CRITICAL ISSUES WERE RAISED BY MHRA DURING INSPECTION.
    * CELADON PHARMACEUTICALS PLC - AS PART OF AUDIT, COMPANY
ALSO
SENT SAMPLES OF ITS API TO AN INDEPENDENT THIRD PARTY FOR
ANALYTICAL TESTING
    * CELADON PHARMACEUTICALS PLC - TESTING CONFIRMED POSITIVE
RESULTS
ACROSS ALL BATCHES, WITH HIGH-QUALITY, CONSISTENT AND
PHARMACEUTICAL-GRADE API PRODUCT
    * CELADON PHARMACEUTICALS PLC - CELADON REMAINS CONFIDENT
THAT
COMPANY WILL OBTAIN REGISTRATION FROM MHRA FOR GMP MANUFACTURING
OF ITS CANNABIS API
    * CELADON PHARMACEUTICALS PLC - DIRECTORS ANTICIPATE
RECEIVING
THIS REGISTRATION DURING Q1 2023.

Source text for Eikon:  ID:nRSV5392Ka 
Further company coverage:  CEL.L 
 ((Reuters.Briefs@thomsonreuters.com;))